![](/img/cover-not-exists.png)
Randomized phase II trial of deferasirox (Exjade???, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
Piga, Antonio, Galanello, Renzo, Forni, Gian Luca, Cappellini, Maria Domenica, Origa, Raffaella, Zappu, Antonietta, Donato, Guido, Bordone, Elena, Lavagetto, Antonella, Zanaboni, Laura, Sechaud, RomaiVolume:
91
Year:
2006
Language:
english
Journal:
Haematologica
DOI:
10.0000/PMID16818273
File:
PDF, 215 KB
english, 2006